Abstract
Substance use disorders (SUDs) are the most costly and prevalent psychiatric conditions. Recent calls emphasize a need for biomarkers—measurable, stable indicators of normal and abnormal processes and response to treatment or environmental agents—and, in particular, brain-based neuromarkers that will advance understanding of the neurobiological basis of SUDs and clinical practice. To develop neuromarkers, researchers must be grounded in evidence that a putative marker (i) is sensitive and specific to the psychological phenomenon of interest, (ii) constitutes a predictive model, and (iii) generalizes to novel observations (e.g., through internal cross-validation and external application to novel data). These neuromarkers may be used to index risk of developing SUDs (susceptibility), classify individuals with SUDs (diagnostic), assess risk for progression to more severe pathology (prognostic) or index current severity of pathology (monitoring), detect response to treatment (response), and predict individualized treatment outcomes (predictive). Here, we outline guidelines for developing and assessing neuromarkers, we then review recent advances toward neuromarkers in addiction neuroscience centering our discussion around neuromarkers of craving—a core feature of SUDs. In doing so, we specifically focus on the Neurobiological Craving Signature (NCS), which show great promise for meeting the demand of neuromarkers.
Similar content being viewed by others
Data Availability
Data for Figure 1 were extracted from PubMed and are available here: https://osf.io/y8u6s/
References
Addiction Cue-Reactivity Initiative (ACRI) Network, Sangchooli A, Zare-Bidoky M, Jouzdani AF, Schacht J, Bjork JM, et al (2024) Parameter space and potential for biomarker development in 25 years of fMRI drug cue reactivity: A systematic review. JAMA Psychiat 81(4):414–425
Ahmed SH (2010) Validation crisis in animal models of drug addiction: beyond non-disordered drug use toward drug addiction. Neurosci Biobehav Rev 35(2):172–184
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington
Bach P, Weil G, Pompili E, Hoffmann S, Hermann D, Vollstädt-Klein S et al (2020) Incubation of neural alcohol cue reactivity after withdrawal and its blockade by naltrexone. Addict Biol 25:e12717
Berridge KC, Robinson TE (2016) Liking, wanting, and the incentive-sensitization theory of addiction. Am Psychol 71(8):670–679
Blaine SK, Seo D & Sinha R (2015) Peripheral and prefrontal stress system markers and risk of relapse in alcoholism. Addict Biol (epub ahead of print)
Boswell RG, Kober H (2016) Food cue reactivity and craving predict eating and weight gain: a meta analytic review. Obes Rev 17(2):159–177
Brewer JA, Mallik S, Babuscio TA, Nich C, Johnson HE, Deleone CM et al (2011) Mindfulness training for smoking cessation: results from a randomized controlled trial. Drug Alcohol Depend 119(1–2):72–80
Buhle JT, Silvers JA, Wager TD, Lopez RB, Onyemekwu C, Kober H et al (2014) Cognitive reappraisal of emotion: a meta-analysis of human neuroimaging studies. Cereb Cortex 24(11):2981–2990
Califf RM (2018) Biomarker definitions and their applications. Exp Biol Med 243(3):213–221
Carroll KM (2021) The profound heterogeneity of substance use disorders: implications for treatment development. Curr Dir Psychol Sci 30(4):358–364
Carroll KM (1998) Therapy manuals for drug addiction, manual 1: a cognitive-behavioral approach: treating cocaine addiction. Rockville
Casey BJ, Cannonier T, Conley MI, Cohen AO, Barch DM, Heitzeg MM et al (2018) The Adolescent Brain Cognitive Development (ABCD) study: Imaging acquisition across 21 sites. Dev Cogn Neurosci 32:43–54
Castellanos-Ryan N, O’Leary-Barrett M, Sully L, Conrod P (2013) Sensitivity and specificity of a brief personality screening instrument in predicting future substance use, emotional, and behavioral problems: 18-month predictive validity of the Substance Use Risk Profile Scale. Alcoholism 37(S1):E281–E290
CDC (2019) The cost of excessive alcohol use. Retrieved from https://www.cdc.gov/alcohol/onlinemedia/infographics/cost-excessive-alcohol-use.html
CDC (2022) Smoking & tobacco use: fast facts and fact sheets. Retrieved from https://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/index.htm
Čeko M, Kragel PA, Woo C-W, López-Solà M, Wager TD (2022) Common and stimulus-type-specific brain representations of negative affect. Nat Neurosci 25(6):760–770
Chang LJ, Gianaros PJ, Manuck SB, Krishnan A, Wager TD (2015) A sensitive and specific neural signature for picture-induced negative affect. PLoS Biol 13(6):e1002180
Chase HW, Eickhoff SB, Laird AR, Hogarth L (2011) The neural basis of drug stimulus processing and craving: an activation likelihood estimation meta-analysis. Biol Psychiat 70(8):785–793
Collins AG, Shenhav A (2022) Advances in modeling learning and decision-making in neuroscience. Neuropsychopharmacology 47:104–118
Contreras M, Ceric F, Torrealba F (2007) Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium. Science 318(5850):655–658
Conway KP, Compton W, Stinson FS, Grant BF (2006) Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 67(2):247–257
Copas JB (1983) Regression, prediction and shrinkage. J R Stat Soc Ser B Stat Methodol 45(3):311–335
Davis KD, Aghaeepour N, Ahn AH, Angst MS, Borsook D, Brenton A et al (2020) Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities. Nat Rev Neurol 16(7):381–400
Devane WA, Dysarz FR, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34(5):605–613
Devane WA, Hanuš L, Breuer A, Pertwee RG, Stevenson LA, Griffin G et al (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258(5090):1946–1949
Di Chiara GD, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci 85(14):5274–5278
Dickson-Gomez J, Weeks M, Green D, Boutouis S, Galletly C, Christenson E (2022) Insurance barriers to substance use disorder treatment after passage of mental health and addiction parity laws and the affordable care act: a qualitative analysis. Drug Alcohol Dependence Reports 3:100051
Ekhtiari H, Zare-Bidoky M, Sangchooli A, Janes AC, Kaufman MJ, Oliver JA et al (2022) A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus. Nat Protoc 17(3):567–595
Eloyan A, Muschelli J, Nebel MB, Liu H, Han F, Zhao T et al (2012) Automated diagnoses of attention deficit hyperactive disorder using magnetic resonance imaging. Front Syst Neurosci 6:61
Engelmann JM, Versace F, Robinson JD, Minnix JA, Lam CY, Cui Y et al (2012) Neural substrates of smoking cue reactivity: a meta-analysis of fMRI studies. Neuroimage 60:252–262
Etkin A, Wager TD (2007) Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 164(10):1476–1488
FDA-NIH Biomarker Working Group (2016) BEST (Biomarkers, EndpointS, and other Tools) Resource. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK326791/
Garavan H, Pankiewicz J, Bloom A, Cho JK, Sperry L, Ross TJ et al (2000) Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 157(11):1789–1798
Garrison KA, Sinha R, Potentza MN, Gao S, Liang Q, Lacadie C, Scheinost D (2023) Transdiagnostic connectome-based prediction of craving. Am J Psychiatry 180(6):445–453
Goldstein RZ, Bechara A, Garavan H, Childress AR, Paulus MP, Volkow ND (2009) The neurocircuitry of impaired insight in drug addiction. Trends Cogn Sci 13(9):372–380
Goldstein-Piekarski AN, Staveland BR, Ball TM, Yesavage J, Korgaonkar MS, Williams LM (2018) Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers. Transl Psychiatry 8(1):57
Goudriaan AE, De Ruiter MB, Van Den Brink W, Oosterlaan J, Veltman DJ (2010) Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. Addict Biol 15(4):491–503
Grosenick L, Klingenberg B, Katovich K, Knutson B, Taylor JE (2013) Interpretable whole-brain prediction analysis with GraphNet. Neuroimage 72:304–321
Hartz SM, Pato CN, Medeiros H, Cavazos-Rehg P, Sobell JL, Knowles JA et al (2014) Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiat 71(3):248–254
Haufe S, Meinecke F, Görgen K, Dähne S, Haynes J-D, Blankertz B, Bießmann F (2014) On the interpretation of weight vectors of linear models in multivariate neuroimaging. Neuroimage 87:96–110
Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJMJ (2021) Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology. https://doi.org/10.1038/s41386-020-00950-y
Herz A (1997) Endogenous opioid systems and alcohol addiction. Psychopharmacology 129:99–111
Hill-Bowen LD, Riedel MC, Poudel R, Salo T, Flannery JS, Camilleri JA et al (2021) The cue-reactivity paradigm: an ensemble of networks driving attention and cognition when viewing drug and natural reward-related stimuli. Neurosci Biobehav Rev 130:201–213
Hughes J, Smith T, Kosterlitz H, Fothergill LA, Morgan B, Morris H (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258(5536):577–579
Huys QJ, Maia TV, Frank MJ (2016) Computational psychiatry as a bridge from neuroscience to clinical applications. Nat Neurosci 19(3):404–413
Hyman SE (2007) Can neuroscience be integrated into the DSM-V? Nat Rev Neurosci 8(9):725–732
Jasinska AJ, Stein EA, Kaiser J, Naumer MJ, Yalachkov Y (2014) Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies. Neurosci Biobehav Rev 38:1–16
Jegerlehner S, Suter-Riniker F, Jent P, Bittel P, Nagler M (2021) Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings. Int J Infect Dis 109:118–122
Koban L, Lee S, Schelski DS, Simon M-C, Lerman C, Weber B et al (2023a) An fMRI-based brain marker of individual differences in delay discounting. J Neurosci 43(9):1600–1613
Koban L, Wager TD, Kober H (2023b) A neuromarker for drug and food craving distinguishes drug users from non-users. Nat Neurosci 26(2):316–325
Kober H (2014) Emotion Regulation in Substance Use Disorders. In: Gross JJ (ed) Handbook of emotion regulation, 2nd edn. Guilford, New York, pp 428–446
Kober H, Mell MM (2015) Neural mechanisms underlying craving and the regulation of craving. In: Wilson SJ (ed) Handbook on the cognitive neuroscience of addiction. UK Wiley-Blackwell, Oxford, pp 195–218
Kober H, Kross EF, Mischel W, Hart CL, Ochsner KN (2010a) Regulation of craving by cognitive strategies in cigarette smokers. Drug Alcohol Depend 106(1):52–55
Kober H, Mende-Siedlecki P, Kross EF, Weber J, Mischel W, Hart CL, Ochsner KN (2010b) Prefrontal-striatal pathway underlies cognitive regulation of craving. Proc Natl Acad Sci 107(33):14811–14816
Kober H, Lacadie CM, Wexler BE, Malison R, Sinha R, Potenza MN (2016) Brain activity during cocaine craving and gambling urges: an fMRI study. Neuropsychopharmacology 41:628–637
Kober H, Buhle J, Weber J, Ochsner KN, Wager TD (2019) Let it be: mindful acceptance down-regulates pain and negative emotion. Soc Cogn Affect Neurosci 14(11):1147–1158
Kohoutova L, Heo J, Cha S, Lee S, Moon T, Wager TD, Woo CW (2020) Toward a unified framework for interpreting machine-learning models in neuroimaging. Nat Protoc 15(4):1399–1435
Konova AB, Schweitzer EM (2023) Decoding craving: Insights from a brain-based connectome predictive model of subjective reports. Am J Psychiatry 180(6):407–409
Koob GF, Volkow ND (2016) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3(8):760–773
Kotov R, Krueger RF, Watson D, Achenbach TM, Althoff RR, Bagby RM et al (2017) The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies. J Abnorm Psychol 126(4):454–477
Kragel PA, Reddan MC, LaBar KS, Wager TD (2019) Emotion schemas are embedded in the human visual system. Sci Adv 5(7):eaaw4358
Kroll DS, Feldman DE, Wang S-YA, Zhang R, Manza P, Wiers CE et al (2020) The associations of comorbid substance use disorders and psychiatric conditions with adolescent brain structure and function: a review. J Neurol Sci 418:117099
Kulkarni KR, Schafer M, Berner LA, Fiore VG, Heflin M, Hutchison K et al (2023) An interpretable and predictive connectivity-based neural signature for chronic cannabis use. Biol Psychiatry Cogn Neurosci Neuroimaging 8(3):320–330
Le Merrer J, Becker JA, Befort K, Kieffer BL (2009) Reward processing by the opioid system in the brain. Physiol Rev 89(4):1379–1412
Lehman CD, Wellman RD, Buist DS, Kerlikowske K, Tosteson AN, Miglioretti DL, Consortium, B. C. S. (2015) Diagnostic accuracy of digital screening mammography with and without computer-aided detection. JAMA Intern Med 175(11):1828–1837
Leshner AI (1997) Addiction is a brain disease, and it matters. Science 278(5335):45–47
Li W, Howard MO, Garland EL, McGovern P, Lazar M (2017) Mindfulness treatment for substance misuse: a systematic review and meta-analysis. J Subst Abuse Treat 75:62–96
Lichenstein SD, Scheinost D, Potenza MN, Carroll KM, Yip SW (2019). Mol Psychiatry 26(8):4383–4393
Lichenstein SD, Scheinost D, Potenza MN, Carroll KM, Yip SW (2021) Dissociable neural substrates of opioid and cocaine use identified via connectome-based modelling. Mol Psychiatry 26(8):4383–4393
Lichenstein SD, Roos CR, Kohler R, Kiluk B, Carroll KM, Worhunsky PD et al (2022) Identification and validation of distinct latent neurodevelopmental profiles in the Adolescent Brain and Cognitive Development study. Biol Psychiatry 7(4):352–361
Lovinger DM, White G, Weight FF (1989) Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243(4899):1721–1724
Lukas SE, Lowen SB, Lindsey KP, Conn N, Tartarini W, Rodolico J et al (2013) Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: a bold FMRI study. Neuroimage 78:176–185
Luo F, Li M, Florence C (2021) State-level economic costs of opioid use disorder and fatal opioid overdose—United States, 2017. Morb Mortal Wkly Rep 70(15):541–546
Lüscher C, Malenka RC (2011) Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 69(4):650–663
MacNiven KH, Jensen EL, Borg N, Padula CB, Humphreys K, Knutson B (2018) Association of neural responses to drug cues with subsequent relapse to stimulant use. JAMA Netw Open 1(8):e186466
Magill M, Ray L, Kiluk B, Hoadley A, Bernstein M, Tonigan JS, Carroll KM (2019) A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: treatment efficacy by contrast condition. J Consult Clin Psychol 87(12):1093–1105
Mameli M, Lüscher C (2011) Synaptic plasticity and addiction: learning mechanisms gone awry. Neuropharmacology 61(7):1052–1059
Marek S, Tervo-Clemmens B, Calabro FJ, Montez DF, Kay BP, Hatoum AS et al (2022) Reproducible brain-wide association studies require thousands of individuals. Nature 603(7902):654–660
Massaly N, Morón JA, Al-Hasani R (2016) A trigger for opioid misuse: chronic pain and stress dysregulate the mesolimbic pathway and kappa opioid system. Front Neurosci. https://doi.org/10.3389/fnins.2016.00480
McMahon FJ (2014) Prediction of treatment outcomes in psychiatry—where do we stand? Dialogues Clin Neurosci 16(4):455–464
Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE et al (1997) Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors. Nature 389(6649):385–389
Möhring L, Gläscher J (2023) Prediction errors drive dynamic changes in neural patterns that guide behavior. Cell Rep 42(8):112931
Mollick JA, Kober H (2020) Computational models of drug use and addiction: a review. J Abnorm Psychol 129(6):544–555
Naqvi NH, Ochsner KN, Kober H, Kuerbis A, Feng T, Wall M, Morgenstern J (2015) Cognitive regulation of craving in alcohol-dependent and social drinkers. Alcoholism 39(2):343–349
Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8(11):1445–1449
Nicosia N, Pacula RL, Kilmer B, Lundberg R & Chiesa J (2009) The economic cost of methamphetamine use in the United States, 2005
NIDA (2020) Common comorbidities with substance use disorders research report. NIH
Nielsen AN, Kaplan S, Meyer D, Alexopoulos D, Kenley JK, Smyser TA et al (2023) Maturation of large-scale brain systems over the first month of life. Cereb Cortex 33(6):2788–2803
Noori HR, Cosa Linan A, Spanagel R (2016) Largely overlapping neuronal substrates of reactivity to drug, gambling, food and sexual cues: a comprehensive meta-analysis. Eur Neuropsychopharmacol 26(9):1419–1430
Palmer RH, Brick L, Nugent NR, Bidwell LC, McGeary JE, Knopik VS, Keller MC (2015) Examining the role of common genetic variants on alcohol, tobacco, cannabis and illicit drug dependence: genetics of vulnerability to drug dependence. Addiction 110(3):530–537
Peters KZ, Cheer JF, Tonini R (2021) Modulating the neuromodulators: dopamine, serotonin, and the endocannabinoid system. Trends Neurosci 44(6):464–477
Petre B, Kragel P, Atlas LY, Geuter S, Jepma M, Koban L et al (2022) A multistudy analysis reveals that evoked pain intensity representation is distributed across brain systems. PLoS Biol 20(5):e3001620
Poldrack RA, Huckins G, Varoquaux G (2020) Establishment of best practices for evidence for prediction: a review. JAMA Psychiat 77(5):534–540
Prendergast M, Podus D, Finney J, Greenwell L, Roll J (2006) Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 101(11):1546–1560
Reddan MC, Lindquist MA, Wager TD (2017) Effect size estimation in neuroimaging. JAMA Psychiat 74(3):207–208
Ritz MC, Lamb R, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237(4819):1219–1223
Roos CR, Bowen S, Witkiewitz K (2017) Baseline patterns of substance use disorder severity and depression and anxiety symptoms moderate the efficacy of mindfulness-based relapse prevention. J Consult Clin Psychol 85(11):1041
Roos CR, Harp N, Vafaie N, Gueorguieva R, Frankforter T, Carroll KM, Kober H (2023) Randomized trial of mindfulness- and reappraisal-based regulation of craving training among daily cigarette smokers. Psychol Addict Behav 37(7):829–840
Schacht JP, Anton RF, Myrick H (2013) Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict Biol 18(1):121–133
Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H, Anton RF (2017) Predictors of naltrexone response in a randomized trial: reward-related brain activation, OPRM1 genotype, and smoking status. Neuropsychopharmacology 42(13):2640–2653
Scheinost D, Noble S, Horien C, Greene AS, Lake EM, Salehi M et al (2019) Ten simple rules for predictive modeling of individual differences in neuroimaging. Neuroimage 193:35–45
Schleifer L, Eldefrawi M (1974) Identification of the nicotinic and muscarinic acetylcholine receptors in subcellular fractions of mouse brain. Neuropharmacology 13(1):53–63
Seo D, Lacadie CM, Tuit K, Hong KI, Constable RT, Sinha R (2013) Disrupted ventromedial prefrontal function, alcohol craving, and subsequent relapse risk. JAMA Psychiat 70(7):727–739
Shen X, Finn ES, Scheinost D, Rosenberg MD, Chun MM, Papademetris X, Constable RT (2017) Using connectome-based predictive modeling to predict individual behavior from brain connectivity. Nat Protocols 12(3):506–518
Simon EJ, Hiller JM, Edelman I (1973) Stereospecific binding of the potent narcotic analgesic [3H] etorphine to rat-brain homogenate. Proc Natl Acad Sci 70(7):1947–1949
Sjoerds Z, van den Brink W, Beekman AT, Penninx BW, Veltman DJ (2014) Cue reactivity is associated with duration and severity of alcohol dependence: an FMRI study. PLoS One 9(1):e84560
Spisak T, Bingel U, Wager TD (2023) Multivariate BWAS can be replicable with moderate sample sizes. Nature 615(7951):E4–E7
Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75(6):406–433
Suzuki S, Mell MM, O’Malley S, Krystal J, Anticevic A, Kober H (2020) Regulation of craving and negative emotion in alcohol use disorder. Biol Psychiatry 5(2):239–250
Tawa EA, Hall SD, Lohoff FW (2016) Overview of the genetics of alcohol use disorder. Alcohol Alcohol 51(5):507–514
Vafaie N, Kober H (2022) Association of drug cues and craving with drug use and relapse: a systematic review and meta-analysis. JAMA Psychiat 79(7):641–650
van’t Hof SR, Van Oudenhove L, Janssen E, Klein S, Reddan MC, Kragel PA et al (2022) The brain activation-based sexual image classifier (BASIC): a sensitive and specific fMRI activity pattern for sexual image processing. Cereb Cortex 32(14):3014–3030
Varoquaux G, Cheplygina V (2022) Machine learning for medical imaging: methodological failures and recommendations for the future. NPJ Digital Med 5(1):48
Volkow ND, Baler RD (2013) Brain imaging biomarkers to predict relapse in alcohol addiction. JAMA Psychiat 70(7):661–663
Volkow ND, Boyle M (2018) Neuroscience of addiction: relevance to prevention and treatment. Am J Psychiatry 175(8):729–740
Volkow ND, Koob G, Baler R (2015) Biomarkers in substance use disorders. ACS Chem Neurosci 6(4):522–525
Volkow ND, Wise RA, Baler R (2017) The dopamine motive system: Implications for drug and food addiction. Nat Rev Neurosci 18(12):741–752
Volkow ND, Michaelides M, Baler R (2019) The neuroscience of drug reward and addiction. Physiol Rev 99(4):2115–2140
Vul E, Harris C, Winkielman P, Pashler H (2009) Puzzlingly high correlations in fMRI studies of emotion, personality, and social cognition. Perspect Psychol Sci 4(3):274–290
Wager TD, Atlas LY, Leotti LA, Rilling JK (2011) Predicting individual differences in placebo analgesia: contributions of brain activity during anticipation and pain experience. J Neurosci 31(2):439–452
Wager TD, Atlas LY, Lindquist MA, Roy M, Woo C-W, Kross E (2013) An fMRI-based neurologic signature of physical pain. N Engl J Med 368(15):1388–1397
Wang X-J, Krystal JH (2014) Computational psychiatry. Neuron 84(3):638–654
Westbrook C, Creswell JD, Tabibnia G, Julson E, Kober H, Tindle HA (2013) Mindful attention reduces neural and self-reported cue-induced craving in smokers. Soc Cogn Affect Neurosci 8(1):73–84
Whelan R, Watts R, Orr CA, Althoff RR, Artiges E, Banaschewski T et al (2014) Neuropsychosocial profiles of current and future adolescent alcohol misusers. Nature 512(7513):185–189
Wittchen HU, Behrendt S, Höfler M, Perkonigg A, Lieb R, Bühringer GE et al (2008) What are the high risk periods for incident substance use and transitions to abuse and dependence? Implications for early intervention and prevention. Int J Methods Psychiatr Res 17(S1):S16–S29
Woo C-W, Chang LJ, Lindquist MA, Wager TD (2017) Building better biomarkers: brain models in translational neuroimaging. Nat Neurosci 20(3):365–377
Yip SW, Scheinost D, Potenza MN, Carroll KM (2019) Connectome-based prediction of cocaine abstinence. Am J Psychiatry 176(2):156–164
Yip SW, Barch DM, Chase HW, Flagel S, Huys QJ, Konova AB et al (2022) From computation to clinic. Biol Psychiatry Global Open Sci 3(3):319–328
Funding
This research was supported by National Institute on Drug Abuse R01 DA043690 (HK), T32 DA022975 (NRH).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Harp, N.R., Wager, T.D. & Kober, H. Neuromarkers in addiction: definitions, development strategies, and recent advances. J Neural Transm 131, 509–523 (2024). https://doi.org/10.1007/s00702-024-02766-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-024-02766-2